Julia Chu

Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)

Patients will be monitored for adverse events following each CTL infusion

Recruiting

Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)

Patients will be monitored for adverse events following the administration of CMV CTLs

Recruiting

Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection

Patients will be followed for adverse events following each infusion of ADV CTLs

Recruiting